JAK2 V617F mutation in myeloid neoplasms with 3q21 and 3q26 abnormalities in Chinese patients.
Wong
K F
KF
Wong
W S
WS
Siu
Lisa L P
LL
Lau
T C
TC
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000754:Anemia, Refractory, with Excess of Blasts / Q000235:genetics; D007446:Chromosome Inversion; D002893:Chromosomes, Human, Pair 3 / Q000235:genetics / Q000648:ultrastructure*; D002897:Chromosomes, Human, Pair 7; D018450:Disease Progression; D005260:Female; D006723:Hong Kong / Q000453:epidemiology; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D007951:Leukemia, Myeloid / Q000453:epidemiology / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009006:Monosomy; D020125:Mutation, Missense; D009190:Myelodysplastic Syndromes / Q000453:epidemiology / Q000235:genetics*; D017354:Point Mutation; D013577:Syndrome; D013922:Thrombocytosis / Q000209:etiology; D014178:Translocation, Genetic
C507924:JAK2 protein, human; D053614:Janus Kinase 2